19-55160687-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001256715.2(DNAAF3):​c.1001T>C​(p.Leu334Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.049 in 1,613,638 control chromosomes in the GnomAD database, including 6,200 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.061 ( 716 hom., cov: 32)
Exomes 𝑓: 0.048 ( 5484 hom. )

Consequence

DNAAF3
NM_001256715.2 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -0.170

Publications

17 publications found
Variant links:
Genes affected
DNAAF3 (HGNC:30492): (dynein axonemal assembly factor 3) The protein encoded by this gene is required for the assembly of axonemal inner and outer dynein arms and plays a role in assembling dynein complexes for transport into cilia. Defects in this gene are a cause of primary ciliary dyskinesia type 2 (CILD2). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
DNAAF3-AS1 (HGNC:55292): (DNAAF3 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004614681).
BP6
Variant 19-55160687-A-G is Benign according to our data. Variant chr19-55160687-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257679.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.21 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001256715.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAAF3
NM_001256715.2
MANE Select
c.1001T>Cp.Leu334Pro
missense
Exon 9 of 12NP_001243644.1
DNAAF3
NM_001256714.1
c.1205T>Cp.Leu402Pro
missense
Exon 9 of 12NP_001243643.1
DNAAF3
NM_178837.4
c.1142T>Cp.Leu381Pro
missense
Exon 9 of 12NP_849159.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAAF3
ENST00000524407.7
TSL:1 MANE Select
c.1001T>Cp.Leu334Pro
missense
Exon 9 of 12ENSP00000432046.3
DNAAF3
ENST00000455045.5
TSL:1
c.839T>Cp.Leu280Pro
missense
Exon 9 of 12ENSP00000394343.1
DNAAF3
ENST00000528412.5
TSL:1
n.*789T>C
non_coding_transcript_exon
Exon 9 of 12ENSP00000433826.2

Frequencies

GnomAD3 genomes
AF:
0.0606
AC:
9217
AN:
152094
Hom.:
706
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0503
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.213
Gnomad ASJ
AF:
0.0214
Gnomad EAS
AF:
0.220
Gnomad SAS
AF:
0.0883
Gnomad FIN
AF:
0.0277
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0266
Gnomad OTH
AF:
0.0680
GnomAD2 exomes
AF:
0.0979
AC:
24271
AN:
248004
AF XY:
0.0855
show subpopulations
Gnomad AFR exome
AF:
0.0506
Gnomad AMR exome
AF:
0.370
Gnomad ASJ exome
AF:
0.0194
Gnomad EAS exome
AF:
0.221
Gnomad FIN exome
AF:
0.0290
Gnomad NFE exome
AF:
0.0265
Gnomad OTH exome
AF:
0.0740
GnomAD4 exome
AF:
0.0478
AC:
69810
AN:
1461426
Hom.:
5484
Cov.:
33
AF XY:
0.0472
AC XY:
34326
AN XY:
727052
show subpopulations
African (AFR)
AF:
0.0496
AC:
1662
AN:
33478
American (AMR)
AF:
0.357
AC:
15958
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.0214
AC:
560
AN:
26124
East Asian (EAS)
AF:
0.242
AC:
9612
AN:
39686
South Asian (SAS)
AF:
0.0832
AC:
7178
AN:
86252
European-Finnish (FIN)
AF:
0.0319
AC:
1692
AN:
53082
Middle Eastern (MID)
AF:
0.0366
AC:
211
AN:
5764
European-Non Finnish (NFE)
AF:
0.0267
AC:
29661
AN:
1111944
Other (OTH)
AF:
0.0542
AC:
3276
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
3674
7348
11022
14696
18370
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1478
2956
4434
5912
7390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0608
AC:
9249
AN:
152212
Hom.:
716
Cov.:
32
AF XY:
0.0645
AC XY:
4799
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.0504
AC:
2095
AN:
41558
American (AMR)
AF:
0.214
AC:
3264
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0214
AC:
74
AN:
3466
East Asian (EAS)
AF:
0.221
AC:
1134
AN:
5130
South Asian (SAS)
AF:
0.0884
AC:
427
AN:
4832
European-Finnish (FIN)
AF:
0.0277
AC:
294
AN:
10610
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0266
AC:
1810
AN:
68012
Other (OTH)
AF:
0.0678
AC:
143
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
402
805
1207
1610
2012
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
104
208
312
416
520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0450
Hom.:
1183
Bravo
AF:
0.0772
TwinsUK
AF:
0.0299
AC:
111
ALSPAC
AF:
0.0288
AC:
111
ESP6500AA
AF:
0.0394
AC:
152
ESP6500EA
AF:
0.0213
AC:
176
ExAC
AF:
0.0859
AC:
10383
Asia WGS
AF:
0.156
AC:
544
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:3
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 15, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:2
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dilated Cardiomyopathy, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Familial restrictive cardiomyopathy Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hypertrophic cardiomyopathy Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.039
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
8.8
DANN
Benign
0.71
DEOGEN2
Benign
0.00055
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.00047
N
LIST_S2
Benign
0.13
T
MetaRNN
Benign
0.0046
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
-2.1
N
PhyloP100
-0.17
PrimateAI
Benign
0.43
T
PROVEAN
Benign
2.4
N
REVEL
Benign
0.28
Sift
Benign
0.34
T
Sift4G
Benign
0.31
T
Polyphen
0.0
B
Vest4
0.035
MPC
0.36
ClinPred
0.0080
T
GERP RS
1.5
PromoterAI
0.072
Neutral
Varity_R
0.066
gMVP
0.55
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs890871; hg19: chr19-55672055; COSMIC: COSV61277470; COSMIC: COSV61277470; API